Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 21 citing Mather: Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Preventio.... (0.07 sec) 

Adipokines and insulin resistance


K Rabe, M Lehrke, KG Parhofer, UC Broedl - Molecular Medicine, 2008 - pubmedcentral.nih.gov
Obesity is associated with an array of health problems in adult and pediatric
populations. Understanding the pathogenesis of obesity and its metabolic
sequelae has advanced rapidly over the past decades. Adipose tissue ...
Cited by 18 - Related articles - All 7 versions

Pleiotropic effects of rimonabant: clinical implications


JP Despres - Current pharmaceutical design, 2009 - ingentaconnect.com
Abstract: Abdominal obesity (high waist circumference) is more strongly
associated with cardiovascular disease and type 2 diabetes than generalized
adiposity (high body mass index). Recent research has highlighted the role ...
Cited by 5 - Related articles - All 4 versions

Lifestyle intervention for prevention of diabetes: determinants of success for future …


C Roumen, EE Blaak, E Corpeleijn - Nutrition Reviews, 2009 - interscience.wiley.com
Lifestyle interventions are reported to reduce the risk of type 2 diabetes in
high-risk individuals after mid- and long-term follow-up. Information on
determinants of intervention outcome and adherence and the mechanisms ...
Cited by 3 - Related articles - All 3 versions

Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change


NR Bennett, MS Boyne, RS Cooper, TY Royal- … - Clinical Endocrinology, 2009 - medscape.com
The exact interactions between adiponectin and ghrelin with adiposity and
glucose intolerance are unclear in free-living individuals. There are few
prospective studies [8] and even fewer in non-white populations. We ...
Cited by 2 - Related articles - All 9 versions

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis


S Li, HJ Shin, EL Ding, RM van Dam - JAMA, 2009 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 3 - Related articles - All 2 versions

Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced …


RB Goldberg - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc
Evidence: Circulating biomarkers of these pathways such as TNF , IL-6,
C-reactive protein (CRP) (inflammation), vascular cellular adhesion molecule-1,
interstitial cellular adhesion molecule-1, E-selectin, von Willebrand ...
Cited by 2 - Related articles - All 3 versions

Development of a type 2 diabetes risk model from a panel of serum biomarkers from the …

- diabetesjournals.org
JA Kolberg, T Jørgensen, RW Gerwien, S … - Diabetes Care, 2009 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS Subjects were selected from the Inter99 cohort, a
longitudinal population-based study of ∼6,600 Danes in a nested case-control
design with the primary outcome of 5-year conversion to type 2 diabetes. ...
Cited by 2 - Related articles - All 4 versions

The Clinical Implications of Blood Adiponectin in Cardiometabolic Disorders

- elsevier.com [PDF] 
LC Chang, KC Huang, YW Wu, HL Kao, CL … - Journal of the Formosan Medical Association, 2009 - Elsevier
Adipose tissue is now accepted by the scientific and medical community to be a
genuine endocrine organ, in addition to its classical role as an energy store.
Adiponectin is one of the many adipocytokines that are secreted almost ...
Cited by 1 - Related articles - All 14 versions

Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic …


Y Kamada, T Nakamura, T Funahashi, M Ryo, … - Journal of Clinical Gastroenterology, 2009 - journals.lww.com
Obesity is an independent risk factor for the progression of chronic liver
diseases, such as nonalcoholic steatohepatitis (NASH), alcoholic liver disease,
chronic hepatitis C, hepatic cirrhosis, and hepatocellular carcino- ...
Related articles - All 5 versions

Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic …


Y Kamada, T Nakamura, T Funahashi, M Ryo, … - Age (y) - pdfs.journals.lww.com
Obesity is an independent risk factor for the progression of chronic liver
diseases, such as nonalcoholic steatohepatitis (NASH), alcoholic liver disease,
chronic hepatitis C, hepatic cirrhosis, and hepatocellular carcino- ...
Related articles


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google